Review



chondrogenic media  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress chondrogenic media
    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of <t>chondrogenic</t> markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Chondrogenic Media, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 38 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/(-)-Blebbistatin/pmc13019076-419-6-18
    Average 95 stars, based on 38 article reviews
    chondrogenic media - by Bioz Stars, 2026-09
    95/100 stars

    Images

    1) Product Images from "Adaptable sliding hydrogels enable pericellular pocket formation while enhancing MSC chondrogenesis and survival in 3D ☆ "

    Article Title: Adaptable sliding hydrogels enable pericellular pocket formation while enhancing MSC chondrogenesis and survival in 3D ☆

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.03.014

    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of chondrogenic markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Figure Legend Snippet: Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of chondrogenic markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.

    Techniques Used: Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Staining, Dimethylmethylene Blue Assay, Immunohistochemical staining

    Integrin β-1 expression and cytoskeletal tension correlate with MSC survival and chondrogenesis in ASG. A) Relative gene expression of integrin β-1 ( ITGB1 ) on day 1 (N = 3). B) Representative western blots for integrin β-1 at day 3 and C) quantification (N = 3). GAPDH is used as a loading control and was run on the same blot. D) Representative immunofluorescent images of z-projected integrin β-1 staining on day 3. Scale bar 5 μm. E) Quantification of relative fluorescent intensity of integrin β-1 staining (N = 15 cells across 3 hydrogels). F) Schematic of experimental timeline for drug studies. CM = chondrogenic media; bleb = blebbistatin. Drugs were administered for the first three days of culture in CM and samples were harvested at day 7 and day 21. G) Cell viability is evaluated using live/dead staining at day 7 and H) quantified as a percent viability (N = 3). Scale bar 100 μm. I) Safranin O staining of final tissue formation outcomes at day 21. Scale bar 100 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P value is obtained using an unpaired two-tailed t -test for A, C, and E and using a two-way ANOVA with Tukey's multiple comparisons test for H.
    Figure Legend Snippet: Integrin β-1 expression and cytoskeletal tension correlate with MSC survival and chondrogenesis in ASG. A) Relative gene expression of integrin β-1 ( ITGB1 ) on day 1 (N = 3). B) Representative western blots for integrin β-1 at day 3 and C) quantification (N = 3). GAPDH is used as a loading control and was run on the same blot. D) Representative immunofluorescent images of z-projected integrin β-1 staining on day 3. Scale bar 5 μm. E) Quantification of relative fluorescent intensity of integrin β-1 staining (N = 15 cells across 3 hydrogels). F) Schematic of experimental timeline for drug studies. CM = chondrogenic media; bleb = blebbistatin. Drugs were administered for the first three days of culture in CM and samples were harvested at day 7 and day 21. G) Cell viability is evaluated using live/dead staining at day 7 and H) quantified as a percent viability (N = 3). Scale bar 100 μm. I) Safranin O staining of final tissue formation outcomes at day 21. Scale bar 100 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P value is obtained using an unpaired two-tailed t -test for A, C, and E and using a two-way ANOVA with Tukey's multiple comparisons test for H.

    Techniques Used: Expressing, Gene Expression, Western Blot, Control, Staining, Two Tailed Test

    Related Articles

    Control:

    Article Title: Adaptable sliding hydrogels enable pericellular pocket formation while enhancing MSC chondrogenesis and survival in 3D
    Article Snippet: .. The following compounds were added to chondrogenic media for the first three days of culture: 50 μM Blebbistatin (MedChem Express); 10 μM Y27632 (Sigma-Aldrich); and DMSO was also added to relevant control groups. .. To conjugate RGD cell-binding domains to SG polymers, the adhesion peptide cysteine–arginine–glycine–aspartate–serine (CRGDS, GenScript) was added to the polymer precursor solution at a concentration of 1 mM.



    Similar Products

    95
    MedChemExpress chondrogenic media
    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of <t>chondrogenic</t> markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Chondrogenic Media, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/(-)-Blebbistatin/pmc13019076-419-6-18
    Average 95 stars, based on 1 article reviews
    chondrogenic media - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    PromoCell chondrogenic differentiation media
    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of <t>chondrogenic</t> markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Chondrogenic Differentiation Media, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/Mesenchymal+Stem+Cell+Chondrogenic+Differentiation+Medium/pm40965742-42-9-13
    Average 95 stars, based on 1 article reviews
    chondrogenic differentiation media - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Thermo Fisher chondrogenic differentiation media stempro
    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of <t>chondrogenic</t> markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Chondrogenic Differentiation Media Stempro, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/stemprotm+chondrogenesis+differentiation+kit/pmc12046811-54-35-30
    Average 90 stars, based on 1 article reviews
    chondrogenic differentiation media stempro - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    PromoCell specialized differentiation media
    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of <t>chondrogenic</t> markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Specialized Differentiation Media, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/Mesenchymal+Stem+Cell+Chondrogenic+Different%2E+Medium/10__1016_slash_j__celbio__2026__100423-262-6-18
    Average 95 stars, based on 1 article reviews
    specialized differentiation media - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Procell Inc chondrogenic induction media
    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of <t>chondrogenic</t> markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.
    Chondrogenic Induction Media, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/chondrogenic+medium/pmc12446538-53-4-7
    Average 86 stars, based on 1 article reviews
    chondrogenic induction media - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Merck & Co chondrogenic differentiation media
    iHF-MSC immortalization and phenotyping. A SV40LT mRNA expression by RT-PCR. GAPDH was employed as a reference gene. Positive Control (C+): SV40T plasmid. Negative Control (C-): non-infected HF-MSCs. B Flow cytometry histograms for iHF-MSC surface markers pre-gated on live cells after doublet discrimination. Percentages shown correspond to the proportion of positive cells for the populations indicated in the legend (in order: isotype, HF-MSCs, C18, C20, C26, C39). Histograms shown are representative of one replicate. Y-axis: Count. C iHF-MSC differentiation ability. Optical micrographs of Alizarin Red S staining for osteogenic differentiation, Oil Red O staining for adipogenic differentiation, and Alcian Blue staining for <t>chondrogenic</t> differentiation. D Epifluorescence microscopy images of CD56 immunostaining (DAPI in blue, CD56 in green). Scale bars = 20 μm. Data are representative of 3 independent experiments with 4 replicates per group. Abbreviations: HF-MSCs: hair follicle-derived mesenchymal stromal cells. iHF-MSCs: immortalized HF-MSCs. C18: clone 18. C20: clone 20. C26: clone 26. C39: clone 39. CD: Cluster of Differentiation. MHC-II: major histocompatibility complex class II
    Chondrogenic Differentiation Media, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/differentiation+media+neuronal/pmc12625642-95-33-36
    Average 86 stars, based on 1 article reviews
    chondrogenic differentiation media - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc chondrogenic differentiation culture media
    iHF-MSC immortalization and phenotyping. A SV40LT mRNA expression by RT-PCR. GAPDH was employed as a reference gene. Positive Control (C+): SV40T plasmid. Negative Control (C-): non-infected HF-MSCs. B Flow cytometry histograms for iHF-MSC surface markers pre-gated on live cells after doublet discrimination. Percentages shown correspond to the proportion of positive cells for the populations indicated in the legend (in order: isotype, HF-MSCs, C18, C20, C26, C39). Histograms shown are representative of one replicate. Y-axis: Count. C iHF-MSC differentiation ability. Optical micrographs of Alizarin Red S staining for osteogenic differentiation, Oil Red O staining for adipogenic differentiation, and Alcian Blue staining for <t>chondrogenic</t> differentiation. D Epifluorescence microscopy images of CD56 immunostaining (DAPI in blue, CD56 in green). Scale bars = 20 μm. Data are representative of 3 independent experiments with 4 replicates per group. Abbreviations: HF-MSCs: hair follicle-derived mesenchymal stromal cells. iHF-MSCs: immortalized HF-MSCs. C18: clone 18. C20: clone 20. C26: clone 26. C39: clone 39. CD: Cluster of Differentiation. MHC-II: major histocompatibility complex class II
    Chondrogenic Differentiation Culture Media, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/chondrogenic+differentiation+medium/pm40507809-218-24-28
    Average 90 stars, based on 1 article reviews
    chondrogenic differentiation culture media - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cyagen Biosciences chondrogenic media
    iHF-MSC immortalization and phenotyping. A SV40LT mRNA expression by RT-PCR. GAPDH was employed as a reference gene. Positive Control (C+): SV40T plasmid. Negative Control (C-): non-infected HF-MSCs. B Flow cytometry histograms for iHF-MSC surface markers pre-gated on live cells after doublet discrimination. Percentages shown correspond to the proportion of positive cells for the populations indicated in the legend (in order: isotype, HF-MSCs, C18, C20, C26, C39). Histograms shown are representative of one replicate. Y-axis: Count. C iHF-MSC differentiation ability. Optical micrographs of Alizarin Red S staining for osteogenic differentiation, Oil Red O staining for adipogenic differentiation, and Alcian Blue staining for <t>chondrogenic</t> differentiation. D Epifluorescence microscopy images of CD56 immunostaining (DAPI in blue, CD56 in green). Scale bars = 20 μm. Data are representative of 3 independent experiments with 4 replicates per group. Abbreviations: HF-MSCs: hair follicle-derived mesenchymal stromal cells. iHF-MSCs: immortalized HF-MSCs. C18: clone 18. C20: clone 20. C26: clone 26. C39: clone 39. CD: Cluster of Differentiation. MHC-II: major histocompatibility complex class II
    Chondrogenic Media, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/chondrogenic+medium/pm40306480-54-19-23
    Average 90 stars, based on 1 article reviews
    chondrogenic media - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Cyagen Biosciences hmsc chondrogenic differentiation media
    iHF-MSC immortalization and phenotyping. A SV40LT mRNA expression by RT-PCR. GAPDH was employed as a reference gene. Positive Control (C+): SV40T plasmid. Negative Control (C-): non-infected HF-MSCs. B Flow cytometry histograms for iHF-MSC surface markers pre-gated on live cells after doublet discrimination. Percentages shown correspond to the proportion of positive cells for the populations indicated in the legend (in order: isotype, HF-MSCs, C18, C20, C26, C39). Histograms shown are representative of one replicate. Y-axis: Count. C iHF-MSC differentiation ability. Optical micrographs of Alizarin Red S staining for osteogenic differentiation, Oil Red O staining for adipogenic differentiation, and Alcian Blue staining for <t>chondrogenic</t> differentiation. D Epifluorescence microscopy images of CD56 immunostaining (DAPI in blue, CD56 in green). Scale bars = 20 μm. Data are representative of 3 independent experiments with 4 replicates per group. Abbreviations: HF-MSCs: hair follicle-derived mesenchymal stromal cells. iHF-MSCs: immortalized HF-MSCs. C18: clone 18. C20: clone 20. C26: clone 26. C39: clone 39. CD: Cluster of Differentiation. MHC-II: major histocompatibility complex class II
    Hmsc Chondrogenic Differentiation Media, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chondrogenic+media/msc+chondrogenic+differentiation+basal+medium/pm40043914-204-10-17
    Average 90 stars, based on 1 article reviews
    hmsc chondrogenic differentiation media - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of chondrogenic markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.

    Journal: Bioactive Materials

    Article Title: Adaptable sliding hydrogels enable pericellular pocket formation while enhancing MSC chondrogenesis and survival in 3D ☆

    doi: 10.1016/j.bioactmat.2026.03.014

    Figure Lengend Snippet: Increasing stress relaxation and plasticity in ASG accelerate MSC-based cartilage formation in 3D . Reverse transcription quantitative-polymerase chain reaction (RT-qPCR) analysis of chondrogenic markers for differentiation including A) transcription factor SRY-box transcription factor 9 ( SOX9 ) and cartilage matrix proteins B) aggrecan ( ACAN ) and C) type-2 collagen ( COL2 ) relative to SG (N = 3-4) and normalized to GAPDH. D) Safranin O staining of cryosectioned hydrogels at day 7 and day 21. Scale bar 75 μm. Quantification of E) day 7 and F) day 21 sulfated glycosaminoglycan (sGAG) content per hydrogel using a dimethylmethylene blue assay (DMMB) (N = 3). G) Immunohistochemical staining for type-2 collagen at day 28. Scale bar 300 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P values are obtained using one-way ANOVA with Tukey's multiple comparisons tests.

    Article Snippet: The following compounds were added to chondrogenic media for the first three days of culture: 50 μM Blebbistatin (MedChem Express); 10 μM Y27632 (Sigma-Aldrich); and DMSO was also added to relevant control groups.

    Techniques: Reverse Transcription, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Staining, Dimethylmethylene Blue Assay, Immunohistochemical staining

    Integrin β-1 expression and cytoskeletal tension correlate with MSC survival and chondrogenesis in ASG. A) Relative gene expression of integrin β-1 ( ITGB1 ) on day 1 (N = 3). B) Representative western blots for integrin β-1 at day 3 and C) quantification (N = 3). GAPDH is used as a loading control and was run on the same blot. D) Representative immunofluorescent images of z-projected integrin β-1 staining on day 3. Scale bar 5 μm. E) Quantification of relative fluorescent intensity of integrin β-1 staining (N = 15 cells across 3 hydrogels). F) Schematic of experimental timeline for drug studies. CM = chondrogenic media; bleb = blebbistatin. Drugs were administered for the first three days of culture in CM and samples were harvested at day 7 and day 21. G) Cell viability is evaluated using live/dead staining at day 7 and H) quantified as a percent viability (N = 3). Scale bar 100 μm. I) Safranin O staining of final tissue formation outcomes at day 21. Scale bar 100 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P value is obtained using an unpaired two-tailed t -test for A, C, and E and using a two-way ANOVA with Tukey's multiple comparisons test for H.

    Journal: Bioactive Materials

    Article Title: Adaptable sliding hydrogels enable pericellular pocket formation while enhancing MSC chondrogenesis and survival in 3D ☆

    doi: 10.1016/j.bioactmat.2026.03.014

    Figure Lengend Snippet: Integrin β-1 expression and cytoskeletal tension correlate with MSC survival and chondrogenesis in ASG. A) Relative gene expression of integrin β-1 ( ITGB1 ) on day 1 (N = 3). B) Representative western blots for integrin β-1 at day 3 and C) quantification (N = 3). GAPDH is used as a loading control and was run on the same blot. D) Representative immunofluorescent images of z-projected integrin β-1 staining on day 3. Scale bar 5 μm. E) Quantification of relative fluorescent intensity of integrin β-1 staining (N = 15 cells across 3 hydrogels). F) Schematic of experimental timeline for drug studies. CM = chondrogenic media; bleb = blebbistatin. Drugs were administered for the first three days of culture in CM and samples were harvested at day 7 and day 21. G) Cell viability is evaluated using live/dead staining at day 7 and H) quantified as a percent viability (N = 3). Scale bar 100 μm. I) Safranin O staining of final tissue formation outcomes at day 21. Scale bar 100 μm ns, not significant; ∗ P < 0.05, ∗∗ P < 0.005, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001. The P value is obtained using an unpaired two-tailed t -test for A, C, and E and using a two-way ANOVA with Tukey's multiple comparisons test for H.

    Article Snippet: The following compounds were added to chondrogenic media for the first three days of culture: 50 μM Blebbistatin (MedChem Express); 10 μM Y27632 (Sigma-Aldrich); and DMSO was also added to relevant control groups.

    Techniques: Expressing, Gene Expression, Western Blot, Control, Staining, Two Tailed Test

    iHF-MSC immortalization and phenotyping. A SV40LT mRNA expression by RT-PCR. GAPDH was employed as a reference gene. Positive Control (C+): SV40T plasmid. Negative Control (C-): non-infected HF-MSCs. B Flow cytometry histograms for iHF-MSC surface markers pre-gated on live cells after doublet discrimination. Percentages shown correspond to the proportion of positive cells for the populations indicated in the legend (in order: isotype, HF-MSCs, C18, C20, C26, C39). Histograms shown are representative of one replicate. Y-axis: Count. C iHF-MSC differentiation ability. Optical micrographs of Alizarin Red S staining for osteogenic differentiation, Oil Red O staining for adipogenic differentiation, and Alcian Blue staining for chondrogenic differentiation. D Epifluorescence microscopy images of CD56 immunostaining (DAPI in blue, CD56 in green). Scale bars = 20 μm. Data are representative of 3 independent experiments with 4 replicates per group. Abbreviations: HF-MSCs: hair follicle-derived mesenchymal stromal cells. iHF-MSCs: immortalized HF-MSCs. C18: clone 18. C20: clone 20. C26: clone 26. C39: clone 39. CD: Cluster of Differentiation. MHC-II: major histocompatibility complex class II

    Journal: Stem Cell Research & Therapy

    Article Title: Immortalized human hair follicle-derived mesenchymal-like stromal cells for the long-term production of scalable Immunomodulatory and regenerative secretome

    doi: 10.1186/s13287-025-04775-8

    Figure Lengend Snippet: iHF-MSC immortalization and phenotyping. A SV40LT mRNA expression by RT-PCR. GAPDH was employed as a reference gene. Positive Control (C+): SV40T plasmid. Negative Control (C-): non-infected HF-MSCs. B Flow cytometry histograms for iHF-MSC surface markers pre-gated on live cells after doublet discrimination. Percentages shown correspond to the proportion of positive cells for the populations indicated in the legend (in order: isotype, HF-MSCs, C18, C20, C26, C39). Histograms shown are representative of one replicate. Y-axis: Count. C iHF-MSC differentiation ability. Optical micrographs of Alizarin Red S staining for osteogenic differentiation, Oil Red O staining for adipogenic differentiation, and Alcian Blue staining for chondrogenic differentiation. D Epifluorescence microscopy images of CD56 immunostaining (DAPI in blue, CD56 in green). Scale bars = 20 μm. Data are representative of 3 independent experiments with 4 replicates per group. Abbreviations: HF-MSCs: hair follicle-derived mesenchymal stromal cells. iHF-MSCs: immortalized HF-MSCs. C18: clone 18. C20: clone 20. C26: clone 26. C39: clone 39. CD: Cluster of Differentiation. MHC-II: major histocompatibility complex class II

    Article Snippet: To do so, cells were seeded at a confluence of 2 × 10 5 cells per well in 96-well U-bottom suspension culture plates and incubated for 24–48 h. Spheroids were then cultured in chondrogenic differentiation media (Merck ready-to-use PromoCell MSC Differentiation Media: C-28012).

    Techniques: Expressing, Reverse Transcription Polymerase Chain Reaction, Positive Control, Plasmid Preparation, Negative Control, Infection, Flow Cytometry, Staining, Epifluorescence Microscopy, Immunostaining, Derivative Assay, Immunopeptidomics